Right as Rain | July 21, 2025
Psilocybin, a hallucinogenic compound in some mushrooms, has therapeutic potential. For some, it is a safe option, but it might not be ideal for everyone. Nathan Sackett is quoted.
News & Stories
NTAP explores psychedelic-assisted treatments
The Daily | March 5, 2025
“I felt pretty frustrated by the limits of our treatments, and so I was hoping to explore other options in terms of potential treatments,” says Nathan Sackett.
UWMC Roosevelt opens new clinical rooms, includes space for research trials
Department News | October 31, 2024
After years of advocacy, our outpatient psychiatry clinic at UWMC Roosevelt has opened more space for patient care and clinical research. The pandemic increased demand for mental health services and at the same time allowed us to pivot to telemedicine. That change increased access to care three-fold, and now, with the public health emergency behind […]
Olympia decriminalizes some psychedelic drugs like mushrooms
KIRO 7 | August 14, 2024
With data on psilocybin showing it can combat depression, anxiety and PTSD, Nathan Sackett, MD, MS, isn't surprised to see more municipalities make decisions to decriminalize it.
Mushrooms may not be magic, but they could be therapeutic
Seattle Met | May 30, 2024
Nathan Sackett, MD, MS, is heading up a study to explore the potential therapeutic value of psilocybin, the psychedelic compound found in mushrooms.
UW’s “magic mushroom” trial advancing
Axios Seattle | April 30, 2024
A study led by Nathan Sackett, MD, MS, on the therapeutic value of psychedelic mushrooms for treating addiction and trauma is on track. The project will enroll about 40 first responders and Veterans with PTSD and alcohol use disorder starting this fall.
Following near disaster for Alaska Airlines, concern over ‘magic mushrooms’ grows
KUOW | October 31, 2023
The recent Alaska Airlines flight emergency is only one example of psychedelic mushrooms making the news this year. Nathan Sackett, MD, MS, says these incidents highlight the need to be very thoughtful and intentional about potential access to these compounds.
Podcast: The untapped potential of psychedelics in psychotherapy
Crosscut | July 27, 2023
Research shows psychedelic drugs such as psilocybin and ketamine can be effective in treating depression, post-traumatic stress and substance-use disorders — but there’s still much we don’t know. Nathan Sackett, MD, MS, acting assistant professor of psychiatry and behavioral sciences in the UW School of Medicine, is interviewed.
UW study looks at benefits of psychedelic mushrooms
KNDO | May 19, 2023
The University of Washington School of Medicine is conducting a study on the therapeutic value of psychedelic mushrooms led by Nathan Sackett, MD.
WA authorizes UW study of ‘magic mushrooms’ as PTSD treatment
MyNorthwest | May 17, 2023
Governor Jay Inslee signed Senate Bill 5263 into law, which mandated a study into psilocybin as well as the creation of a regulatory body for the possible recreational and medical use of the drug. Leading the upcoming study will be Dr. Nathan Sackett, with the University of Washington’s Department of Psychiatry and Behavioral Sciences.